EXPLORE MORE CATEGORIES
- Home
- ยป
- Our Products
- »
- Pharmaceutical Injections
Pharmaceutical Injections
Providing you the best range of testoviron depot 250mg/ml, mero 1g injection, amino acid (8%) injection (nirmin hepa 8% injection), amino acids injection (sterimino 10% w/v injection), cerebroprotein hydrolysate (cerebrolysin 10ml) and leugard 22.5mg injection with effective & timely delivery.
Testoviron Depot 250mg/Ml
Product Price: Rs 210 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 250 mg/ml |
| Packaging Size | 1 ml |
| Brand Name | Testoviron Depot |
| Manufacturer | Zydus Cadila |
| Usage/Application | Treatment of Male hypogonadism |
Testoviron Depot 250 mg/mL
Indications:Testoviron Depot, containing testosterone enanthate, is primarily indicated for:
- Hormone replacement therapy in men with low testosterone levels (hypogonadism).
- Conditions associated with testosterone deficiency, such as decreased libido, fatigue, and muscle weakness.
Testosterone enanthate is an anabolic steroid that promotes the development of male secondary sexual characteristics. It works by binding to androgen receptors, leading to an increase in protein synthesis, muscle mass, and overall physical strength.
Dosage and Administration:- Dosage: The typical starting dose is 250 mg administered intramuscularly every 2 to 4 weeks. Specific dosing may vary based on individual needs and physician recommendations.
- Administration: Inject deep intramuscularly, preferably into the gluteal muscle. Rotate injection sites to minimize discomfort.
- Hypersensitivity to testosterone or any components of the formulation.
- Prostate or breast cancer in men.
- Severe liver or kidney disease.
- Pregnancy or breastfeeding.
- Cardiovascular Risks: Monitor for signs of cardiovascular disease, as testosterone therapy can increase the risk of cardiovascular events.
- Hormonal Imbalances: Regularly assess testosterone levels and adjust dosage accordingly to avoid excess testosterone.
- Sleep Apnea: Use with caution in patients with sleep apnea.
- Liver Function: Monitor liver function tests periodically.
Common side effects:
- Acne
- Mood swings
- Increased hair growth (hirsutism)
- Water retention
- Injection site reactions
Serious side effects:
- Severe allergic reactions
- Elevated blood pressure
- Liver dysfunction
- Increased risk of blood clots
Testoviron Depot may interact with medications affecting liver enzymes or hormone levels. Inform healthcare providers of all medications, including over-the-counter drugs and supplements.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze.
Patient Counseling Information:- Advise patients to report any signs of allergic reactions, mood changes, or unusual physical symptoms.
- Emphasize the importance of adhering to the prescribed dosage and schedule.
- Encourage regular follow-up appointments for monitoring testosterone levels and overall health.
Testoviron Depot is an effective option for testosterone replacement therapy, enhancing quality of life for men with low testosterone levels. Ongoing communication with healthcare providers is essential for optimizing treatment and managing potential side effects. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Mero 1g Injection
Product Price: Rs 450 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 1 gm |
| Pack Type | Vial |
| Brand Name | Mero |
| Manufacturer | Aristo |
| Usages | Hospital |
| Prescription/Non Prescription | Prescription |
| Injectable Form | Sterile Powder |
| Drug Name | Meropenem 1gm |
Mero 1 g Injection (Meropenem)
Indications:Meropenem is indicated for the treatment of:
- Complicated skin and soft tissue infections.
- Complicated intra-abdominal infections.
- Community-acquired pneumonia.
- Hospital-acquired pneumonia, including ventilator-associated pneumonia.
- Meningitis in pediatric patients.
Meropenem is a broad-spectrum carbapenem antibiotic that inhibits bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), leading to bacterial cell lysis and death. It is effective against a wide range of gram-positive and gram-negative bacteria, including many resistant strains.
Dosage and Administration:- Dosage: The usual adult dosage is 1 g administered intravenously every 8 hours. For severe infections, higher doses may be required. Pediatric dosing is typically based on weight.
- Administration: Administer via slow intravenous infusion over 30 minutes. Ensure proper hydration and monitor for any infusion reactions.
- Hypersensitivity to meropenem or any component of the formulation.
- History of severe allergic reactions to beta-lactam antibiotics (e.g., penicillins, cephalosporins).
- Allergic Reactions: Monitor for signs of anaphylaxis; discontinue use if severe allergic reactions occur.
- CNS Effects: Caution in patients with a history of seizures; meropenem may lower the seizure threshold.
- Clostridium difficile: Risk of C. difficile-associated diarrhea; monitor for gastrointestinal symptoms.
Common side effects:
- Nausea
- Diarrhea
- Headache
- Rash
- Injection site reactions (pain, swelling)
Serious side effects:
- Severe allergic reactions (anaphylaxis)
- Seizures
- Clostridium difficile infection
- Superinfection with resistant organisms
Meropenem may interact with other medications that affect renal function or are also cleared by the kidneys. Always inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Reconstituted solutions should be used immediately or stored refrigerated and used within 24 hours.
Patient Counseling Information:- Advise patients to complete the full course of therapy, even if they feel better.
- Encourage reporting of any severe side effects, especially signs of allergic reactions or gastrointestinal symptoms.
- Emphasize the importance of hydration during treatment.
Mero 1 g Injection (Meropenem) is a vital broad-spectrum antibiotic used for various serious infections. Regular monitoring and communication with healthcare providers are essential to manage potential side effects and optimize treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Amino Acid (8%) Injection (Nirmin Hepa 8% Injection)
Product Price: Rs 340 / BottleGet Best Price
Product Brochure
Product Details:
| Package Size | 500 ml |
| Concentration | 8% |
| Packaging Size | 500 ml |
| Country of Origin | Made in India |
| Brand | Nirmin Hepa |
| Manufacturer | Aculife |
| Treatment | Nutritional lacks |
Amino Acid (8%) Injection (Nirmin Hepa 8% Injection)
Indications:Nirmin Hepa 8% Injection is indicated for:
- Nutritional support in patients who are unable to meet their nutritional requirements through oral intake.
- Conditions requiring parenteral nutrition, such as gastrointestinal disorders, severe burns, trauma, or postoperative recovery.
This injection typically contains a blend of essential and non-essential amino acids, providing a balanced source of protein for patients who need nutritional supplementation.
Mechanism of Action:Amino acids are the building blocks of proteins and play crucial roles in various physiological processes, including tissue repair, immune function, and hormone production. The infusion of amino acids helps to maintain nitrogen balance, support anabolism, and promote recovery in patients who are unable to consume adequate nutrition orally.
Dosage and Administration:- Dosage: The dosage of Nirmin Hepa 8% Injection is determined by the patient’s nutritional requirements, clinical condition, and body weight.
- Administration: It is administered intravenously. The infusion rate should be adjusted based on the patient's tolerance and clinical response.
- Known hypersensitivity to any component of the formulation.
- Severe liver dysfunction or metabolic disorders that prevent proper amino acid utilization.
- Fluid Overload: Monitor for signs of fluid overload, especially in patients with heart or kidney issues.
- Electrolyte Imbalance: Regular monitoring of electrolytes is essential, as amino acid infusions can affect electrolyte levels.
- Liver Function: Use cautiously in patients with liver disease, as their ability to metabolize amino acids may be compromised.
Common side effects:
- Nausea
- Vomiting
- Headache
- Local irritation at the injection site
Serious side effects:
- Anaphylactic reactions (rare)
- Hyperammonemia
- Electrolyte imbalances
Amino acid injections may interact with medications affecting fluid and electrolyte balance. Inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Advise patients about the importance of adhering to the prescribed dosage and infusion schedule.
- Discuss potential side effects and the need for regular monitoring of clinical status and laboratory parameters.
- Encourage patients to report any unusual symptoms, such as allergic reactions or significant gastrointestinal distress.
Nirmin Hepa 8% Injection is a valuable option for providing nutritional support to patients who cannot meet their nutritional needs through oral intake. Continuous communication with healthcare providers is essential for managing potential side effects and optimizing patient outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Amino Acids Injection (Sterimino 10% W/V Injection)
Product Price: Rs 408 / BottleGet Best Price
Product Brochure
Product Details:
| Package Size | 500 ml |
| Concentration | 10% |
| Packaging Size | 500 ml |
| Brand | Sterimino |
| Manufacturer | linux |
| Treatment | Nutritional inadequacies |
| Composition | AMINOACID (10% W/N) |
Amino Acids Injection (Sterimino 10% W/V Injection)
Indications: Sterimino 10% is primarily used for:
- Parenteral Nutrition: Providing essential amino acids to patients who are unable to obtain adequate nutrition via oral or enteral routes.
- Support During Surgery or Trauma: To promote protein synthesis and prevent muscle wasting.
- Chronic Illness: In conditions that lead to protein loss or increased protein requirements.
Composition: Each 10% w/v solution typically contains a mix of essential and non-essential amino acids, tailored to meet the nutritional needs of patients.
Mechanism of Action: Amino acids are the building blocks of proteins, crucial for various bodily functions, including tissue repair, enzyme production, and hormone synthesis. Administering amino acids intravenously ensures immediate availability for metabolic processes.
Dosage and Administration:
- Dosage: The dosage depends on the individual patient’s requirements, which can vary based on factors like age, weight, and clinical condition. Typically, dosages may range from 1 to 2 grams of amino acids per kilogram of body weight per day.
- Administration: Given as an intravenous infusion. The rate of administration should be adjusted based on the patient’s tolerance and clinical condition.
Contraindications:
- Hypersensitivity to any component of the formulation.
- Severe renal impairment or hepatic coma.
- Inborn errors of amino acid metabolism.
Warnings and Precautions:
- Monitoring: Patients should be closely monitored for fluid balance, electrolytes, and overall nutritional status.
- Renal Function: Caution in patients with renal impairment; dosage adjustments may be necessary.
- Overdose: Excessive amino acid administration can lead to hyperaminoacidemia, which may cause metabolic disturbances.
Side Effects:
- Common: Nausea, vomiting, diarrhea, and injection site reactions.
- Serious: Allergic reactions, fluid overload, and metabolic imbalances.
Drug Interactions: Inform healthcare providers about all medications being taken, especially those that may affect renal function or protein metabolism.
Storage: Store at room temperature (15°C to 25°C / 59°F to 77°F). Protect from light. Do not freeze. Once opened, use as per local guidelines.
Patient Counseling Information:
- Discuss the purpose of the injection and any potential side effects.
- Encourage reporting of any unusual symptoms or reactions during treatment.
Conclusion: Sterimino 10% Amino Acids Injection is a critical component of parenteral nutrition, ensuring patients receive essential nutrients when they cannot eat adequately. Close monitoring and proper administration are key to achieving optimal therapeutic outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Cerebroprotein Hydrolysate (Cerebrolysin 10ml)
Product Price: Rs 650 / PieceGet Best Price
Minimum Order Quantity: 10 Piece
Product Brochure
Product Details:
| Strength | 215.2mg |
| Packaging Size | 10ml |
| Brand | Cerebrolysin |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Usage/Application | Head injury |
| Composition | Cerebroprotein Hydrolysate 215.2mg |
Cerebroprotein Hydrolysate (Cerebrolysin 10 ml)
Indications: Cerebrolysin is primarily used for:
- Cognitive Disorders: Such as Alzheimer’s disease, vascular dementia, and other neurodegenerative conditions.
- Stroke: To support recovery following acute ischemic strokes.
- Traumatic Brain Injury: As an adjunct therapy in rehabilitation.
- Cerebral Ischemia: To improve cognitive function in patients with compromised brain perfusion.
Mechanism of Action: Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from porcine brain tissue. It is thought to exert neuroprotective effects by:
- Enhancing neuronal survival and regeneration.
- Modulating neurotransmitter systems.
- Improving metabolic processes in neurons and glial cells.
Dosage and Administration:
- Dosage: Typically, the recommended dosage ranges from 5 to 30 ml, depending on the condition being treated. Specific dosing regimens may vary based on individual patient needs and response.
- Administration: Can be administered via intravenous or intramuscular injection. The solution should be used immediately after opening.
Contraindications:
- Hypersensitivity to Cerebrolysin or any of its components.
- Severe renal impairment.
- Pregnancy and breastfeeding (unless deemed necessary by a physician).
Warnings and Precautions:
- Allergic Reactions: Monitor for signs of hypersensitivity during administration.
- Renal Function: Use cautiously in patients with impaired renal function.
- Monitoring: Patients should be monitored for any adverse reactions, especially during the initial treatment phase.
Side Effects:
- Common: Mild reactions at the injection site, headache, dizziness, and gastrointestinal disturbances.
- Serious: Allergic reactions (anaphylaxis) and severe hypersensitivity reactions, though these are rare.
Drug Interactions: Cerebrolysin may interact with other medications that affect the central nervous system. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature, protected from light. Once opened, use the solution immediately, and do not freeze.
Patient Counseling Information:
- Instruct patients on the proper administration technique if they are to self-administer.
- Advise reporting any unusual symptoms or side effects promptly.
- Discuss the importance of adhering to follow-up appointments for ongoing evaluation.
Conclusion: Cerebrolysin (Cerebroprotein Hydrolysate) is a therapeutic option for various cognitive and neurological disorders, with a focus on improving recovery and brain function. Close monitoring and professional guidance are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized advice regarding its use.
Yes! I am InterestedRequest A Callback
Leugard 22.5mg Injection
Product Price: Rs 12,500 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 22.5 mg |
| Brand | Leugard |
| Manufacturer | Zydus Cadila |
| Packaging Size | 1*1 |
| Treatment | Prostate cancer |
Yes! I am InterestedRequest A Callback
Mero 250mg Meropenam Injection
Product Price: Rs 185 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 250 mg |
| Pack Type | Vial |
| Brand Name | Mero |
| Manufacturer | Aristo |
| Usages | Hospital |
| Prescription/Non Prescription | Prescription |
Mero 250 mg Injection (Meropenem)
Indications:Meropenem is indicated for the treatment of:
- Complicated skin and soft tissue infections.
- Complicated intra-abdominal infections.
- Community-acquired pneumonia.
- Hospital-acquired pneumonia, including ventilator-associated pneumonia.
- Meningitis in pediatric patients.
Meropenem is a broad-spectrum carbapenem antibiotic that works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) in bacteria, leading to cell lysis and death. It is effective against a wide range of gram-positive and gram-negative bacteria, including many strains that are resistant to other antibiotics.
Dosage and Administration:- Dosage: The usual adult dosage is 500 mg to 1 g every 8 hours, depending on the severity of the infection and the patient's renal function. For pediatric patients, dosing is based on weight.
- Administration: Administered by slow intravenous infusion over 30 minutes. Ensure proper hydration and monitor for infusion-related reactions.
- Hypersensitivity to meropenem or any component of the formulation.
- History of severe allergic reactions to beta-lactam antibiotics (e.g., penicillins, cephalosporins).
- Severe Allergic Reactions: Monitor for signs of anaphylaxis; discontinue use if a serious allergic reaction occurs.
- CNS Effects: Caution in patients with a history of seizures; may lower seizure threshold.
- Clostridium difficile: Risk of C. difficile-associated diarrhea; monitor for gastrointestinal symptoms.
Common side effects:
- Nausea and vomiting
- Diarrhea
- Headache
- Rash
- Injection site reactions (pain, swelling)
Serious side effects:
- Severe allergic reactions (anaphylaxis)
- Seizures
- Clostridium difficile infection
- Superinfection with resistant organisms
Meropenem may interact with other medications that affect renal function or those that are also cleared by the kidneys. Always inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Reconstituted solutions should be used immediately or stored refrigerated and used within 24 hours.
Patient Counseling Information:- Inform patients about the importance of completing the full course of antibiotics, even if they feel better.
- Advise patients to report any severe side effects, particularly signs of allergic reactions or gastrointestinal symptoms.
- Encourage hydration and monitoring for any unusual symptoms during treatment.
Mero 250 mg Injection (Meropenem) is an effective broad-spectrum antibiotic for various serious infections. Regular monitoring and communication with healthcare providers are essential to optimize treatment outcomes and manage potential side effects. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Mero 500mg Meropenam Injection
Product Price: Rs 469 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Strength | 500 mg |
| Pack Type | Vial |
| Brand Name | Mero |
| Manufacturer | Aristo |
| Usages | Hospital |
| Prescription/Non Prescription | Prescription |
| Injection Site | IV Only |
| Drug Name | Meropenam 500mg |
Mero 500 mg Injection (Meropenem)
Indications: Mero (Meropenem) is primarily indicated for:
- Complicated Intra-abdominal Infections: Such as peritonitis.
- Complicated Skin and Skin Structure Infections: Including diabetic foot infections.
- Pneumonia: Specifically in patients with ventilator-associated pneumonia.
- Bacterial Meningitis: In pediatric patients.
- Febrile Neutropenia: As part of empirical therapy in febrile neutropenic patients.
Mechanism of Action: Meropenem is a broad-spectrum carbapenem antibiotic that works by:
- Inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is effective against a wide range of gram-positive and gram-negative bacteria, including many resistant strains.
Dosage and Administration:
- Dosage: The typical dosage for adults ranges from 500 mg to 2 g every 8 hours, depending on the severity of the infection and the specific indication. Dosages may vary for pediatric patients.
- Administration: Given as an intravenous infusion or injection. The reconstitution and dilution instructions should be followed according to the manufacturer's guidelines.
Contraindications:
- Hypersensitivity to meropenem or any component of the formulation.
- History of serious allergic reactions to beta-lactam antibiotics (penicillins, cephalosporins).
Warnings and Precautions:
- Allergic Reactions: Monitor for signs of anaphylaxis or severe allergic reactions, especially in patients with a history of allergies to beta-lactam antibiotics.
- Seizure Risk: Caution in patients with a history of seizures or central nervous system disorders, as meropenem may increase the risk of seizures in susceptible individuals.
- Renal Function: Adjustments in dosing may be necessary in patients with renal impairment.
Side Effects:
- Common: Nausea, vomiting, diarrhea, headache, and rash.
- Serious: Clostridium difficile-associated diarrhea, allergic reactions, seizures, and renal impairment (rare).
Drug Interactions: Inform healthcare providers about all medications being taken, particularly those affecting renal function or that may increase seizure risk.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) before reconstitution. Once reconstituted, follow specific storage instructions regarding refrigeration and use within a certain time frame.
Patient Counseling Information:
- Emphasize the importance of completing the full course of antibiotics, even if symptoms improve.
- Advise patients to report any unusual symptoms, particularly severe gastrointestinal symptoms or allergic reactions.
Conclusion: Mero (Meropenem) 500 mg Injection is a critical option for treating severe bacterial infections. Close monitoring and professional guidance are essential to ensure safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Luprova 22.5 mg Injection
Product Price: Rs 10,000 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Strength | 22.5 mg |
| Pack Size | 1 Injection in 1 Vial |
| Composition | Leuprolide 22.5 mg |
| Brand Name | Luprova |
| Manufacturer | Celon Laboratories Ltd |
| Treatment | Prostate cancer, Breast cancer, Endometriosis, Precocious puberty |
Luprova 22.5 mg Injection
Overview:
Luprova (Leuprorelin acetate) 22.5 mg is a long-acting gonadotropin-releasing hormone (GnRH) agonist used in the treatment of hormone-sensitive conditions, including prostate cancer, endometriosis, uterine fibroids, and precocious puberty. It works by suppressing the production of sex hormones (testosterone and estrogen), which helps to manage conditions driven by these hormones.
Indications:
Luprova 22.5 mg is indicated for:
- Prostate Cancer: Used in advanced prostate cancer to reduce testosterone levels and slow cancer progression.
- Endometriosis: To reduce pain and prevent the growth of endometrial tissue.
- Uterine Fibroids: To shrink fibroids and alleviate symptoms like heavy bleeding and pelvic pain.
- Precocious Puberty: To delay early puberty in children by suppressing premature sex hormone release.
Mechanism of Action:
Luprova is a GnRH agonist that initially stimulates the pituitary gland, causing a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Over time, it desensitizes the pituitary gland, leading to a dramatic decrease in LH and FSH production. This results in reduced production of testosterone in men and estrogen in women, effectively controlling hormone-driven conditions.
Dosage and Administration:
- Recommended Dose: Luprova 22.5 mg is typically administered as an intramuscular injection every 3 months for prostate cancer, endometriosis, and uterine fibroids. For precocious puberty, dosing may be adjusted based on the patient’s weight and specific needs.
- Administration: The injection is given intramuscularly, typically by a healthcare professional. It can be provided as a prefilled syringe or reconstituted before injection.
Side Effects:
- Common Side Effects: Hot flashes, fatigue, headache, nausea, and injection site reactions.
- Serious Side Effects: Osteoporosis, cardiovascular risks, mood changes, and liver dysfunction.
- Long-Term Risks: Extended use may lead to bone thinning, requiring monitoring for signs of osteoporosis.
Precautions:
- Bone Health: Monitor bone density during long-term treatment.
- Pregnancy and Breastfeeding: Contraindicated during pregnancy and breastfeeding.
- Heart Disease: Use cautiously in patients with cardiovascular risk factors.
Storage:
Store at room temperature (15°C to 30°C), away from light, and out of reach of children.
Conclusion:
Luprova 22.5 mg injection is a crucial treatment for hormone-sensitive conditions like prostate cancer, endometriosis, and uterine fibroids, suppressing sex hormones to control disease progression. Regular monitoring for side effects, particularly bone health, is essential for safe use.
Yes! I am InterestedRequest A Callback
Insugen-R Refil Insulin Injection
Product Price: Rs 195 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 100 IU/ml |
| Form | Injection |
| Packaging Type | Box |
| Brand | Biocon |
| Usage / Application | Clinical |
| Shelf Life | 24 Months |
| Medicine brand | Insugen-r |
| Medicine form | Injection |
| Medicine name | Insulin injection |
| Medicine strength | 1u/ml |
| Packaging size | 5 x 3 ml |
| Packaging type | Cartridges |
| Salt composition | Soluble insulin, neutral |
Yes! I am InterestedRequest A Callback
Emeset 2ml Injection
Product Price: Rs 950 / PieceGet Best Price
Product Brochure
Product Details:
| Packaging Size | 2ml |
| Usage/Application | Hospital |
| Brand | Emeset |
| Manufacturer | Cipla |
| Country of Origin | Made in India |
Yes! I am InterestedRequest A Callback
Rituximab Injection 100 Mg ( Rituxirel 100 Mg )
Product Price: Rs 3,000 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Strength | 100 mg |
| Packaging Type | Vial |
| Packaging Size | 10 ml |
| Brand | Rituxirel |
| Manufacturer | Reliance Life Sciences |
| Storage | Store in a refrigerator (2 - 8 DegreeC). Do not freeze. |
Rituximab Injection (Rituxirel 100 mg)
Indications:Rituximab is indicated for:
- Treatment of certain types of non-Hodgkin lymphoma (NHL).
- Chronic lymphocytic leukemia (CLL).
- Granulomatosis with polyangiitis (Wegener’s granulomatosis).
- Microscopic polyangiitis.
- Rheumatoid arthritis (in combination with methotrexate) in adult patients who have had an inadequate response to other therapies.
Rituximab is a chimeric monoclonal antibody that targets the CD20 antigen found on the surface of B cells. It induces B cell depletion through mechanisms including complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, and direct apoptosis.
Dosage and Administration:- Dosage: The typical dosing varies based on the condition being treated. For NHL, a common regimen is 375 mg/m² administered as an intravenous infusion. For rheumatoid arthritis, it’s usually 1000 mg on day 1 and day 15, in combination with methotrexate.
- Administration: Administer via slow intravenous infusion. Monitor patients closely during the first infusion for signs of infusion reactions.
- Hypersensitivity to rituximab or any component of the formulation.
- Active severe infections.
- Infusion Reactions: Monitor for infusion-related reactions, especially during the first infusion. Pre-medication with antihistamines and corticosteroids may be required.
- Infections: Rituximab can increase the risk of serious infections, including progressive multifocal leukoencephalopathy (PML).
- Cardiovascular Events: Use with caution in patients with pre-existing cardiovascular conditions.
- Hepatitis B Virus Reactivation: Monitor patients at risk for HBV reactivation.
Common side effects:
- Infusion reactions (fever, chills, rigors, rash)
- Nausea
- Fatigue
- Headache
Serious side effects:
- Severe allergic reactions
- Infections (including PML)
- Cardiac complications
- Hepatitis B virus reactivation
Rituximab may interact with other immunosuppressive agents or medications that increase infection risk. Inform healthcare providers of all medications being taken.
Storage:Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Patient Counseling Information:- Advise patients to report any signs of infusion reactions, infections, or unusual symptoms.
- Discuss the importance of adherence to the treatment regimen and attending follow-up appointments.
- Encourage patients to maintain good hygiene and avoid contact with sick individuals.
Rituximab Injection (Rituxirel 100 mg) is an effective treatment option for various hematological malignancies and autoimmune conditions. Continuous communication with healthcare providers is essential for managing side effects and optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Maball 500mg 50ml Injection
Product Price: Rs 28,000 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Strength | 500 mg |
| Packaging Type | Vial |
| Packaging Size | 50 ml |
| Brand | Maball-RA |
| Manufacturer | Hetero Healthcare Limited |
Maball-RA 500 mg/50 mL Injection
Indications:Maball-RA, which contains rituximab, is primarily indicated for:
- Treatment of rheumatoid arthritis in adult patients, particularly in those who have had an inadequate response to other therapies.
- Treatment of certain types of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
- Granulomatosis with polyangiitis and microscopic polyangiitis.
Rituximab is a chimeric monoclonal antibody that targets the CD20 antigen on B cells. By binding to CD20, it leads to the destruction of these cells through mechanisms such as complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, and direct induction of apoptosis.
Dosage and Administration:- Dosage: The typical dose for rheumatoid arthritis is 1000 mg administered as an intravenous infusion, often given in two doses (day 1 and day 15) in combination with methotrexate.
- Administration: Infuse slowly intravenously. Monitor patients closely during the first infusion for potential infusion reactions. Pre-medication with antihistamines and corticosteroids may be recommended.
- Hypersensitivity to rituximab or any component of the formulation.
- Active severe infections.
- Infusion Reactions: Patients should be monitored for infusion-related reactions, especially during the initial infusion. Symptoms may include fever, chills, and rigors.
- Infection Risk: Increased risk of serious infections, including progressive multifocal leukoencephalopathy (PML), should be considered.
- Cardiovascular Events: Caution is advised in patients with a history of cardiovascular disease.
- Hepatitis B Virus Reactivation: Monitor patients who are at risk for hepatitis B reactivation.
Common side effects:
- Infusion-related reactions (fever, chills, rash)
- Nausea
- Fatigue
- Headache
Serious side effects:
- Severe allergic reactions
- Serious infections
- Hepatitis B reactivation
- Cardiac complications
Rituximab may interact with other medications that affect immune function or increase infection risk. It’s important to inform healthcare providers about all current medications.
Storage:Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Patient Counseling Information:- Advise patients to report any signs of infusion reactions, infections, or unusual symptoms promptly.
- Discuss the importance of adhering to the prescribed treatment plan and attending regular follow-up appointments.
- Encourage good hygiene practices to minimize infection risk.
Maball-RA 500 mg/50 mL Injection is an effective treatment option for rheumatoid arthritis and certain hematological malignancies. Ongoing communication with healthcare providers is crucial for managing potential side effects and ensuring optimal treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Denosumab (Denosurel 120mg Injection)
Product Price: Rs 18,500 / PieceGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 120 mg |
| Packaging Type | Vial |
| Manufactured By | Reliance Life Sciences |
| Brand | Denosurel |
| Usage/Application | Osteoporosis |
Denosumab Injection (Denosurel 120 mg)
Indications:Denosumab is indicated for:
- Treatment of osteoporosis in postmenopausal women at high risk of fracture.
- Treatment of osteoporosis in men at high risk of fracture.
- Prevention of skeletal-related events in patients with bone metastases from solid tumors.
- Treatment of giant cell tumor of bone in adults and skeletally mature adolescents.
Denosumab is a monoclonal antibody that inhibits RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), a key protein involved in the formation, function, and survival of osteoclasts (the cells that break down bone). By blocking RANKL, denosumab decreases bone resorption and increases bone density.
Dosage and Administration:- Dosage: The typical dose for osteoporosis is 60 mg subcutaneously every six months. For patients with bone metastases, the dose is often 120 mg subcutaneously every month.
- Administration: Denosumab is administered as a subcutaneous injection. It can be injected into the upper arm, thigh, or abdomen. Proper technique and hygiene should be followed to minimize injection site reactions.
- Hypersensitivity to denosumab or any component of the formulation.
- Hypocalcemia (low calcium levels).
- Hypocalcemia: Patients should be monitored for signs of hypocalcemia, which may require correction before starting treatment.
- Infections: Increased risk of serious infections, including skin infections, has been reported.
- Osteonecrosis of the Jaw (ONJ): There is a risk of ONJ, particularly in patients receiving high doses for cancer treatment. Dental examination and preventive dental care are advised before starting therapy.
- Fractures: Discontinuation of denosumab may lead to rapid bone loss and increase the risk of fractures.
Common side effects:
- Injection site reactions (pain, swelling, redness)
- Back pain
- Musculoskeletal pain
- Constipation
Serious side effects:
- Hypocalcemia
- Serious infections
- Osteonecrosis of the jaw (ONJ)
- Atypical femoral fractures
Denosumab may interact with medications affecting calcium levels or immune function. Inform healthcare providers of all medications being taken.
Storage:Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Patient Counseling Information:- Advise patients to report any signs of infection, jaw pain, or unusual thigh or groin pain.
- Discuss the importance of maintaining adequate calcium and vitamin D intake during treatment.
- Encourage regular dental check-ups and good oral hygiene.
Denosumab (Denosurel 120 mg) is an effective treatment for osteoporosis and conditions associated with bone loss. Continuous communication with healthcare providers is essential for managing potential side effects and ensuring optimal treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Bacillus Calmette-Guerin strain ( Onco Bcg 40mg Injection)
Product Price: Rs 450 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Packaging Type | Vial |
| Brand | Onco BCG |
| Treatment | Treatment of Early-stage bladder cancer |
| Manufactured By | Cipla |
| Country of Origin | Made in India |
| Strength | 40 mg |
Bacillus Calmette-Guerin (BCG) Injection (Onco BCG 40 mg)
Indications:Onco BCG is primarily indicated for:
- Intravesical treatment of superficial bladder cancer (transitional cell carcinoma) to reduce the risk of recurrence following transurethral resection.
- Treatment of carcinoma in situ of the bladder.
BCG is a live attenuated strain of Mycobacterium bovis that stimulates a local immune response. When instilled into the bladder, it activates the immune system, leading to the destruction of cancer cells through a combination of immune-mediated effects.
Dosage and Administration:- Dosage: The standard dosing regimen for superficial bladder cancer typically consists of weekly intravesical instillations of 40 mg of BCG for 6 weeks. Additional maintenance therapy may be considered based on the physician's recommendation and patient's condition.
- Administration: BCG is administered intravesically (into the bladder) by a healthcare professional. Proper technique should be followed to minimize irritation and infection.
- Active urinary tract infections (UTIs).
- Patients with severely compromised immune systems.
- Individuals with a history of hypersensitivity to BCG or any component of the formulation.
- Pregnant or breastfeeding women.
- Infection Risk: Patients may be at increased risk for systemic infections. Monitor for signs of infection after administration.
- Bladder Irritation: Commonly causes local bladder irritation (e.g., dysuria, frequency, urgency), which usually resolves after treatment.
- Autoimmune Disorders: Use with caution in patients with autoimmune disorders, as BCG can provoke immune responses.
Common side effects:
- Bladder irritation (dysuria, increased urinary frequency)
- Hematuria (blood in urine)
- Fever and chills
- Fatigue
Serious side effects:
- Systemic infections (including disseminated BCG infection)
- Severe allergic reactions
- Pneumonitis
BCG may interact with immunosuppressive agents. Inform healthcare providers of all medications being taken, especially those affecting the immune system.
Storage:Store at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze.
Patient Counseling Information:- Advise patients to report any signs of infection, persistent fever, or unusual symptoms.
- Discuss potential side effects related to bladder irritation and the importance of hydration.
- Encourage patients to maintain good hygiene to minimize infection risk.
Bacillus Calmette-Guerin (Onco BCG 40 mg) is an effective intravesical treatment for superficial bladder cancer, stimulating the immune system to help prevent recurrence. Continuous communication with healthcare providers is essential for managing side effects and ensuring optimal treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Dextran 40 + Sodium Chloride (Microspan NS 10gm/0.9gm Infusion)
Product Price: Rs 225 / BoxGet Best Price
Minimum Order Quantity: 10 Box
Product Brochure
Product Details:
| Pack Size | 500 ml |
| Strength | 0.9% |
| Brand | Microspan NS |
| Country of Origin | Made in India |
| Packaging Size | 500 ml in 1 bottle |
| Manufacturer | Claris Lifesciences Ltd |
| Composition | Dextran 40 (10gm) + Sodium Chloride (0.9gm) |
| Prescription/Non prescription | Prescription |
Dextran 40 + Sodium Chloride (Microspan NS 10 g/0.9 g Infusion)
Indications: Microspan NS is primarily indicated for:
- Volume Replacement: As a colloid solution to expand plasma volume in cases of shock, severe dehydration, or during surgical procedures.
- Improvement of Microcirculation: In certain clinical situations where enhanced blood flow is beneficial.
Mechanism of Action:
- Dextran 40: A synthetic colloid that increases osmotic pressure and helps maintain plasma volume by drawing fluid into the vascular space.
- Sodium Chloride: A balanced electrolyte that helps maintain osmotic equilibrium and proper fluid balance in the body.
Dosage and Administration:
- Dosage: The exact dosage will depend on the clinical situation and patient response. Typically administered as an intravenous infusion, under the supervision of healthcare professionals.
- Administration: Administered slowly through an intravenous line, with careful monitoring of the patient’s response to treatment.
Contraindications:
- Hypersensitivity to dextran or any component of the formulation.
- Severe renal impairment or anuria.
- Heart failure or fluid overload conditions.
- Active bleeding or coagulopathy.
Warnings and Precautions:
- Monitoring: Close monitoring of fluid balance, kidney function, and vital signs during administration is essential.
- Allergic Reactions: There is a potential risk of anaphylaxis or hypersensitivity reactions; observe for any signs of allergy.
- Electrolyte Imbalance: Monitor for possible electrolyte imbalances, particularly in patients with underlying conditions.
Side Effects:
- Common: Fever, rash, headache, and nausea.
- Serious: Anaphylactic reactions, fluid overload, and renal impairment.
Drug Interactions: Always inform healthcare providers about all medications being taken, as dextran can interact with anticoagulants and other medications affecting coagulation.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about the purpose of the infusion and the importance of monitoring.
- Advise patients to report any signs of allergic reactions or unusual symptoms during treatment.
Conclusion: Microspan NS (Dextran 40 + Sodium Chloride) is an effective volume-expanding solution used in various clinical situations. Careful monitoring and professional administration are essential for optimizing treatment outcomes and minimizing risks. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Menogon Menotrophin 75 IU Injection
Product Price: Rs 650 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 75iu |
| Formulation | Highly Purified (HP) |
| Packaging Type | Vial |
| Dose Strength | 75IU |
| Manufactured By | Ferring Pharmaceuticals |
| Usage/Application | Female infertility |
| Storage Instruction | Store in a refrigerator (2 - 8 DegreeC). Do not freeze. |
Menogon Menotrophin 75 IU Injection
Indications:Menogon is indicated for:
- Ovulation induction in women with anovulation or oligo-ovulation, especially in cases like polycystic ovary syndrome (PCOS).
- Stimulation of ovarian follicle development in women undergoing assisted reproductive technologies (ART), such as in vitro fertilization (IVF).
- Treatment of male hypogonadotropic hypogonadism to stimulate spermatogenesis.
Menogon contains menotropins (FSH and LH), which are gonadotropins essential for reproductive function.
- Follicle-Stimulating Hormone (FSH) promotes the growth and maturation of ovarian follicles.
- Luteinizing Hormone (LH) triggers ovulation and supports the production of progesterone and estrogen.
By providing these hormones, Menogon facilitates the development of eggs in women and supports sperm production in men.
Dosage and Administration:- Dosage: The typical starting dose is 75 IU administered subcutaneously or intramuscularly. Dosage may be adjusted based on the patient's response and specific treatment goals.
- Administration: Usually given once daily, with the exact timing and duration determined by the healthcare provider.
- Hypersensitivity to menotropins or any component of the formulation.
- Primary ovarian insufficiency or uncontrolled thyroid/adrenal dysfunction.
- Tumors of the ovary, uterus, or breast.
- Ovarian Hyperstimulation Syndrome (OHSS): Monitor for signs of OHSS, which can occur with fertility treatments and may lead to serious complications.
- Multiple Pregnancies: Increased risk of multiple pregnancies with fertility treatments.
- Monitoring: Regular monitoring of hormone levels and ultrasound assessments may be necessary to evaluate follicle development.
Common side effects:
- Injection site reactions (pain, redness, swelling)
- Headache
- Abdominal discomfort or bloating
- Mood swings
Serious side effects:
- Ovarian hyperstimulation syndrome (OHSS)
- Allergic reactions
- Thromboembolic events
Menogon may interact with other medications affecting hormone levels. Patients should inform their healthcare providers about all medications they are taking, including hormonal therapies.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Instruct patients on proper injection technique and rotation of injection sites.
- Emphasize the importance of attending follow-up appointments for monitoring.
- Discuss potential side effects and when to seek medical attention, especially for signs of OHSS or severe allergic reactions.
Menogon Menotrophin 75 IU Injection is an effective option for treating fertility issues in both women and men. Close adherence to the treatment plan and communication with healthcare providers are essential for achieving the best possible outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Cidofovir Vistide 375 mg (75 mg/ml) injection
Product Price: Rs 35,000 / PieceGet Best Price
Minimum Order Quantity: 10 Piece
Product Brochure
Product Details:
| Strength | 375 mg |
| Generic Name | Cidofovir |
| Packaging Size | 75 mg/ml |
| Medicine Type | Allopathic |
| Brand | Vistide |
| Manufactured by | Gilead |
| Packing Type | Vial |
| Country of Origin | Made in India |
| Treatment | Cytomegalovirus (CMV) Retinitis |
| Prescription/Non prescription | Non Prescription |
Cidofovir (Vistide) 375 mg Injection
Indications:Cidofovir is indicated for:
- The treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS).
- It may also be used in other conditions as determined by a healthcare provider, especially in cases of viral infections resistant to other antiviral therapies.
Cidofovir is an antiviral agent that inhibits viral DNA synthesis. It is a nucleotide analog of cytosine that, once phosphorylated, competes with natural nucleotides for incorporation into viral DNA. This incorporation results in the termination of viral DNA chain elongation, ultimately leading to viral replication inhibition.
Dosage and Administration:- Dosage: The recommended dosage for the treatment of CMV retinitis is typically 5 mg/kg administered intravenously once a week. Specific dosing may vary based on patient condition and response.
- Administration: Administered as an intravenous infusion over a period of 1 hour. It is important to ensure proper hydration before and after administration to reduce the risk of nephrotoxicity.
- Hypersensitivity to cidofovir or any components of the formulation.
- Renal impairment or a history of significant renal dysfunction.
- Nephrotoxicity: Monitor renal function closely, as cidofovir can cause renal impairment. Prehydration and co-administration of probenecid can help mitigate this risk.
- Ocular Effects: Monitor for signs of retinal detachment and other ocular side effects.
- Use in Pregnant Women: Caution is advised, as cidofovir may cause fetal harm.
Common side effects:
- Nephrotoxicity (increased serum creatinine)
- Nausea
- Vomiting
- Diarrhea
- Headache
Serious side effects:
- Severe renal toxicity
- Ocular toxicity, including retinal detachment
- Allergic reactions
Cidofovir may interact with other medications that affect renal function or have nephrotoxic potential. Always inform healthcare providers of all medications, including over-the-counter drugs and supplements.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Protect from light and do not freeze. Keep out of reach of children.
Patient Counseling Information:- Advise patients about the importance of hydration before and after treatment to reduce nephrotoxicity risk.
- Discuss potential side effects, particularly regarding renal function and ocular health, and when to seek medical attention.
- Encourage adherence to follow-up appointments for monitoring renal function and overall treatment response.
Cidofovir (Vistide) 375 mg Injection is an important treatment for CMV retinitis in immunocompromised patients, requiring careful monitoring and management to minimize potential side effects. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Tosiban 37.5mg Injection
Product Price: Rs 100 / StripGet Best Price
Minimum Order Quantity: 10 Strip
Product Brochure
Product Details:
| Dose | 37.5 mg |
| Packaging Size | 5 ml Injection in 1 vial |
| Composition | Atosiban Acetate 7.5mg/ml |
| Brand | Tosiban |
| Manufacturer | Zuventus Healthcare Ltd |
| Usage/Application | Premature Labor |
Yes! I am InterestedRequest A Callback
Enoxaparin Injection(Evaparin 300mg Injection)
Product Price: Rs 2,100 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Strength | 300mg/3ml |
| Packaging Size | 3 ml in 1 cartridge |
| Composition | Enoxaparin 300mg |
| Brand Name | Evaparin |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Usages | Treatment and prevention of Blood clots |
| Dose | 300 mg/3 ml |
Enoxaparin Injection (Evaparin 300 mg Injection)
Indications:Enoxaparin is indicated for:
- Prophylaxis of deep vein thrombosis (DVT) in patients undergoing surgery or immobilization.
- Treatment of DVT and pulmonary embolism (PE).
- Prevention of thrombus formation in patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI).
- Adjunct therapy in ST elevation myocardial infarction (STEMI) in conjunction with percutaneous coronary intervention (PCI).
Enoxaparin is a low molecular weight heparin (LMWH) that inhibits factor Xa and factor IIa (thrombin) in the coagulation cascade. This anticoagulant effect helps prevent the formation and growth of blood clots.
Dosage and Administration:- Dosage: The typical dosage for prophylaxis of DVT is 40 mg subcutaneously once daily, while treatment of DVT or PE may require 1 mg/kg subcutaneously every 12 hours or 1.5 mg/kg once daily, depending on the clinical scenario.
- Administration: Administered via subcutaneous injection in the abdomen or thigh. Rotate injection sites to minimize irritation.
- Hypersensitivity to enoxaparin or any component of the formulation.
- Active major bleeding or a history of heparin-induced thrombocytopenia (HIT).
- Severe renal impairment (creatinine clearance <30 mL/min).
- Bleeding Risk: Increased risk of bleeding; monitor for signs of bleeding, especially in patients with concurrent anticoagulant therapy.
- Renal Function: Use with caution in patients with renal impairment, as dosage adjustments may be necessary.
- Spinal or Epidural Anesthesia: Caution in patients undergoing procedures involving spinal or epidural anesthesia due to the risk of hematoma.
Common side effects:
- Injection site reactions (pain, bruising, hematoma)
- Nausea
- Mild elevation of liver enzymes
Serious side effects:
- Severe bleeding
- Thrombocytopenia (low platelet count)
- Allergic reactions (anaphylaxis)
Enoxaparin may interact with other anticoagulants, antiplatelet agents, and NSAIDs. Always inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Instruct patients on proper injection techniques and the importance of rotating injection sites.
- Advise patients to report any signs of unusual bleeding or bruising.
- Discuss the importance of regular follow-up appointments for monitoring.
Enoxaparin Injection (Evaparin 300 mg) is an effective anticoagulant used for the prevention and treatment of thromboembolic disorders. Close monitoring and communication with healthcare providers are essential for optimizing treatment outcomes and managing potential side effects. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Vancomycin Vanking 1000 mg injection
Product Price: Rs 449 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 1 g |
| Composition | Vancomycin 1gm |
| Brand | Vanking 1gm |
| Manufacturer | Neon |
| Form | Injection |
| Treatment | Serious Bacterial Diseases |
| Prescription/Non prescription | Prescription |
Vanking (Vancomycin) 1000 mg Injection
Overview: Vanking is an injectable antibiotic used primarily to treat serious infections caused by gram-positive bacteria, particularly those resistant to other antibiotics.
Indications:
- Serious Infections: Effective for treating infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
- Skin and Soft Tissue Infections: Used for complicated skin infections.
- Endocarditis: Treatment of infections involving the heart valves.
- Bone and Joint Infections: Indicated for osteomyelitis and septic arthritis.
Mechanism of Action: Vancomycin works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is effective against a range of gram-positive bacteria.
Dosage and Administration:
- Dosage: The usual dosing regimen varies based on the infection type, patient age, weight, and renal function. For serious infections, a typical initial dose might be 15 to 20 mg/kg every 8 to 12 hours.
- Administration: Administered intravenously; should be given over at least 60 minutes to reduce the risk of infusion-related reactions.
Contraindications:
- Hypersensitivity to vancomycin or any component of the formulation.
- Caution in patients with a history of hypersensitivity reactions to other glycopeptide antibiotics.
Warnings and Precautions:
- Monitor renal function regularly, as vancomycin can be nephrotoxic.
- Watch for signs of infusion-related reactions, such as "Red Man Syndrome," characterized by flushing and rash.
Side Effects:
- Common: Nausea, vomiting, chills, fever, and injection site reactions.
- Serious: Risk of nephrotoxicity, ototoxicity, and severe allergic reactions.
Drug Interactions: Use with caution in combination with other nephrotoxic drugs or medications that affect renal function.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients about potential side effects, especially those related to infusion reactions.
- Advise reporting any unusual symptoms, such as severe rash, dizziness, or changes in hearing.
Conclusion: Vanking (Vancomycin) 1000 mg injection is an important treatment option for serious bacterial infections. Proper administration and monitoring are essential for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Fulvestrant Injection (Fulzos 250mg/5ml Injection)
Product Price: Rs 12,000 / BoxGet Best Price
Minimum Order Quantity: 10 Box
Product Brochure
Product Details:
| Strength | 250 mg |
| Packaging Type | Box |
| Manufactured By | Hetero Healthcare Limited |
| Country of Origin | Made in India |
| Storage | Store in a refrigerator (2 - 8 DegreeC). Do not freeze. |
| Brand | Fulzos |
| Usage/Application | Breast cancer |
| Prescription/Non prescription | Prescription |
| Composition | Fulvestrant 250 mg Injection |
Fulvestrant Injection (Fulzos 250 mg/5 mL Injection)
Indications:Fulvestrant is indicated for:
- The treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women, particularly in those who have progressed on prior endocrine therapy.
Fulvestrant is an estrogen receptor antagonist that works by binding to estrogen receptors in breast tissue, leading to:
- Downregulation of estrogen receptors.
- Inhibition of estrogen-mediated signaling pathways.
- Induction of apoptosis in hormone-sensitive breast cancer cells.
- Dosage: The typical starting dose is 500 mg administered intramuscularly (IM) as two separate injections of 250 mg each on day 0. This is followed by 250 mg IM on days 14 and 28, and then every month thereafter.
- Administration: Administered as an intramuscular injection in the gluteal muscle. Rotate injection sites to minimize discomfort.
- Hypersensitivity to fulvestrant or any component of the formulation.
- Pregnancy and breastfeeding.
- Bone Health: Monitor bone health in patients at risk for osteoporosis or fractures, as fulvestrant does not prevent bone loss.
- Liver Function: Use caution in patients with hepatic impairment, as fulvestrant is metabolized by the liver.
- Tumor Lysis Syndrome: Monitor for signs of tumor lysis syndrome in patients with a high tumor burden.
Common side effects:
- Hot flashes
- Nausea
- Fatigue
- Injection site reactions (pain, swelling)
- Headache
Serious side effects:
- Hepatotoxicity
- Severe allergic reactions
- Thromboembolic events
Fulvestrant may interact with other medications that affect hepatic enzymes. Always inform healthcare providers of all medications being taken, including over-the-counter drugs and supplements.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. Protect from light and keep out of reach of children.
Patient Counseling Information:- Instruct patients on the proper administration technique and the importance of rotating injection sites.
- Discuss potential side effects, especially the risk of hot flashes and fatigue, and when to seek medical attention.
- Emphasize adherence to follow-up appointments for monitoring treatment effectiveness and any side effects.
Fulvestrant Injection (Fulzos 250 mg/5 mL) is a vital treatment option for postmenopausal women with hormone receptor-positive metastatic breast cancer. Regular monitoring and communication with healthcare providers are essential to optimize treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Piracetam NOOTROPIL 200mg injection
Product Price: Rs 118 / BoxGet Best Price
Minimum Order Quantity: 10 Box
Product Brochure
Product Details:
| Dose/Strength | 200mg |
| Packaging Size | 200mg/15ml |
| Brand | Nootropil |
| Manufactured By | Dr Reddy's Laboratories Ltd |
| Composition | Piracetam 200mg |
| Usage/Application | Alzheimer's disease |
Piracetam (Nootropil) 200 mg Injection
Indications: Piracetam is used for:
- Cognitive Enhancement: To improve cognitive function in conditions such as dementia and cognitive impairment.
- Myoclonus: As an adjunctive therapy in the treatment of myoclonus associated with epilepsy.
- Stroke Rehabilitation: To aid in recovery from stroke or head injury.
Mechanism of Action: Piracetam is a nootropic that enhances neuronal function. It is believed to work by:
- Modulating neurotransmitter activity (especially acetylcholine).
- Improving blood flow and oxygen consumption in the brain.
- Enhancing synaptic plasticity, which is crucial for learning and memory.
Dosage and Administration:
- Dosage: Typically, the initial dose may range from 1.6 to 4.8 g/day, divided into several doses. The specific dosage for injection should be determined by a healthcare professional based on the patient's needs.
- Administration: Administered intravenously or intramuscularly. The injection should be done carefully, typically in a clinical setting.
Contraindications:
- Hypersensitivity to piracetam or any component of the formulation.
- Severe renal impairment (adjustments may be necessary).
- Pregnancy and breastfeeding (use only if the benefits outweigh risks).
Warnings and Precautions:
- Monitoring: Patients should be monitored for potential side effects and therapeutic effectiveness.
- Renal Function: Use with caution in patients with impaired renal function; dosage adjustments may be necessary.
- Behavioral Changes: Monitor for any changes in behavior or mood.
Side Effects:
- Common: Headache, nervousness, insomnia, gastrointestinal disturbances, and dizziness.
- Serious: Rarely, may cause severe allergic reactions or bleeding disorders.
Drug Interactions: Piracetam may interact with anticoagulants and other CNS-active medications. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature, protected from light. Follow specific storage instructions as provided by the manufacturer.
Patient Counseling Information:
- Discuss potential side effects and the importance of reporting any adverse reactions.
- Advise on the need for follow-up appointments to monitor progress and adjust treatment as necessary.
Conclusion: Piracetam (Nootropil) 200 mg Injection is a nootropic agent used for cognitive enhancement and treatment of myoclonus. Proper administration and monitoring are crucial for safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Neostigmine(Myostigmin 2.5mg Injection)
Product Price: Rs 89 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 2.5mg |
| Brand | Myostigmin |
| Composition | neostigmine 2.5mg |
| Packaging Size | 5ml |
| Packaging Type | 5*5 ampoule of 5ml |
| Manufacturer | Neon |
| Dose | 2.5mg |
Neostigmine (Myostigmin 2.5 mg Injection)
Indications: Myostigmin (Neostigmine) is primarily indicated for:
- Myasthenia Gravis: To improve muscle strength in patients with this autoimmune neuromuscular disorder.
- Postoperative Urinary Retention: To stimulate bladder function after surgery.
- Reversal of Neuromuscular Blockade: Used in anesthetic practice to reverse the effects of non-depolarizing neuromuscular blockers.
Mechanism of Action: Neostigmine is an acetylcholinesterase inhibitor that works by:
- Preventing the breakdown of acetylcholine at the neuromuscular junction, which increases the concentration of acetylcholine available to stimulate muscle contractions.
- Enhancing communication between nerves and muscles, thereby improving muscle strength.
Dosage and Administration:
- Dosage: The typical dose for myasthenia gravis is 2.5 mg administered subcutaneously or intramuscularly, with adjustments based on individual response. For reversal of neuromuscular blockade, dosages may vary, typically ranging from 0.5 to 2.5 mg administered intravenously.
- Administration: Administered by healthcare professionals, particularly in cases involving the reversal of neuromuscular blockers.
Contraindications:
- Hypersensitivity to neostigmine or any component of the formulation.
- Mechanical intestinal or urinary obstruction.
Warnings and Precautions:
- Cholinergic Crisis: Monitor for signs of cholinergic crisis (e.g., excessive salivation, muscle weakness), which can lead to respiratory failure.
- Cardiovascular Effects: Use with caution in patients with bradycardia or other cardiac conditions, as neostigmine can affect heart rate.
Side Effects:
- Common: Nausea, vomiting, diarrhea, abdominal cramps, increased salivation, and sweating.
- Serious: Severe bradycardia, muscle cramps, or signs of cholinergic crisis.
Drug Interactions: Neostigmine may interact with other medications, especially those affecting neuromuscular transmission or having anticholinergic effects. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
Patient Counseling Information:
- Educate patients or caregivers on the importance of adhering to prescribed doses and recognizing signs of cholinergic crisis.
- Advise reporting any unusual symptoms, such as excessive salivation or muscle weakness.
Conclusion: Myostigmin (Neostigmine) 2.5 mg Injection is an effective treatment for managing myasthenia gravis and reversing neuromuscular blockade. Close monitoring and professional administration are essential for safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Citicoline Injection (Neticol 2 Ml Injection)
Product Price: Rs 170 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Brand | Neticol |
| Prescription/Non prescription | Prescription |
| Manufacturer | neon |
| Country of Origin | Made in India |
| Form | Injection |
| Treatment | Treatment of Head injury |
Citicoline Injection (Neticol 2 mL Injection)
Indications:Neticol is indicated for:
- Treatment of cognitive dysfunctions, including memory impairment and attention deficits.
- Management of stroke or traumatic brain injury to aid in recovery.
- Neuroprotective therapy in conditions such as Alzheimer's disease and other neurodegenerative disorders.
Citicoline is a precursor of phosphatidylcholine, an essential component of cell membranes. It enhances the synthesis of phospholipids, promotes neuronal membrane repair, and supports neurotransmitter synthesis (especially acetylcholine). This leads to improved neuronal function and protection against cellular injury.
Dosage and Administration:- Dosage: The typical dosage for citicoline injection is 1 g (5 mL) daily, which may vary based on the clinical condition and patient response.
- Administration: Administered intravenously or intramuscularly. For intravenous use, it can be diluted in a suitable solution and infused over a specific period, depending on the healthcare provider's recommendations.
- Hypersensitivity to citicoline or any components of the formulation.
- Caution in patients with severe renal or hepatic impairment.
- Hemodynamic Stability: Monitor vital signs, especially in patients with a history of cardiovascular issues.
- Pregnancy and Lactation: Use with caution; consult a healthcare provider before administration.
- Seizure History: Use cautiously in patients with a history of seizures.
Common side effects:
- Headache
- Nausea
- Insomnia
- Gastrointestinal discomfort
Serious side effects:
- Allergic reactions (rare)
- Elevated blood pressure or heart rate
Citicoline generally has a low potential for drug interactions. However, inform healthcare providers of all medications being taken, especially those affecting blood pressure or central nervous system function.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
Patient Counseling Information:- Advise patients about the purpose of the injection and what to expect during treatment.
- Discuss potential side effects and the importance of reporting any unusual symptoms.
- Encourage patients to maintain a healthy lifestyle to support cognitive function, including proper nutrition and mental exercises.
Citicoline Injection (Neticol 2 mL) is an effective neuroprotective agent used to support cognitive function and recovery from neurological injuries. Regular communication with healthcare providers is essential for monitoring effects and optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Terifrac Solo 600mcg Injection (Teriparatide)
Product Price: Rs 4,250 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 600 mcg |
| Pack Size | 2.4ml |
| Composition | Teriparatide 600 mcg |
| Shelf Life | 24 Months |
| Usage/Application | To Treat Osteoporosis |
| Brand Name | Terifrac |
| Manufacturer By | Intas Pharmaceuticals Ltd |
| Uses | Osteoporosis |
Overview: Terifrac Solo is an injectable formulation containing Teriparatide, a synthetic form of parathyroid hormone (PTH) used in the treatment of osteoporosis.
Indications:- Osteoporosis: Indicated for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture.
- Bone Density Improvement: Used to increase bone mineral density and reduce the risk of vertebral and non-vertebral fractures.
Teriparatide works by stimulating osteoblast activity, which leads to increased bone formation. It enhances calcium absorption in the intestines and decreases renal excretion of calcium, contributing to improved bone density and strength.
Dosage and Administration:- Dosage: The typical dose for adults is usually 600 mcg administered subcutaneously once daily. The exact regimen may vary based on individual patient needs and healthcare provider recommendations.
- Administration: Should be injected into the thigh or abdomen. Patients may be trained to self-administer the injection after proper instruction from a healthcare provider.
- Common Side Effects: May include:
- Nausea
- Dizziness
- Injection site reactions (redness, swelling, pain)
- Serious Side Effects: Rare but can include:
- Hypercalcemia (high calcium levels)
- Allergic reactions
- Hypersensitivity: Should not be used in individuals with known allergies to Teriparatide or any components of the formulation.
- Bone Metastases or Paget’s Disease: Contraindicated in patients with active bone metastases or skeletal malignancies.
- Monitoring: Regular monitoring of calcium levels is essential during treatment to avoid complications.
- Risk of Osteosarcoma: There may be an increased risk of osteosarcoma; patients with pre-existing conditions affecting bone should be monitored closely.
Inform your healthcare provider about all medications being taken, particularly those affecting calcium metabolism or bone health.
Storage Instructions:Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of Terifrac Solo and the importance of adhering to the treatment regimen.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially related to calcium levels.
- Emphasize the need for follow-up appointments to monitor treatment effectiveness and safety.
Terifrac Solo (600 mcg Injection - Teriparatide) is an effective treatment for osteoporosis, helping to improve bone density and reduce fracture risk. Always consult healthcare professionals for personalized medical advice and treatment plans.
Yes! I am InterestedRequest A Callback
Expavon 6% injection
Product Price: Rs 635 / VialGet Best Price
Product Brochure
Product Details:
| Packaging Size | 500 ml |
| Strength | 6% w/v |
| Composition | HydroxyEthyle Starch 6% |
| Brand Name | Expavon |
| Manufacturer | Neon Laboratories Ltd |
| Usage | Momentary Liquid Substitution After Injury |
Yes! I am InterestedRequest A Callback
Remicade Infliximab 100 Mg Injection
Product Price: Rs 12,749 / VialGet Best Price
Product Brochure
Product Details:
| Drug Strength | 100 mg |
| Pack Type | Vial |
| Brand Name | Remicade |
| Manufacturer | Janssen |
| Usages | Rheumatoid arthritis,Ankylosing spondylitis,Psoriasis,Ulcerative colitis,Crohn's disease |
| Shelf Life | 24 months |
| Prescription Type | Non-Prescription |
Remicade (Infliximab) 100 mg Injection
Indications: Remicade (Infliximab) is primarily indicated for:
- Rheumatoid Arthritis: Treatment of adult patients in combination with methotrexate.
- Crohn's Disease: Treatment of adults and pediatric patients with moderate to severe active Crohn's disease.
- Ulcerative Colitis: Treatment of adults with moderate to severe ulcerative colitis.
- Ankylosing Spondylitis: Treatment of adults with active ankylosing spondylitis.
- Psoriatic Arthritis: Treatment of adult patients with active psoriatic arthritis.
- Plaque Psoriasis: Treatment of adults with chronic severe plaque psoriasis.
Mechanism of Action: Infliximab is a monoclonal antibody that works by:
- Binding to tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine. This binding prevents TNF-alpha from interacting with its receptors, leading to reduced inflammation and immune response.
Dosage and Administration:
- Dosage:
- The initial dose varies by indication but generally starts with 5 mg/kg administered as an intravenous infusion. Subsequent doses are given at weeks 2 and 6, followed by maintenance doses every 8 weeks.
- Administration: Administered as an intravenous infusion over at least 2 hours. Pre-medication with antihistamines or corticosteroids may be considered to reduce infusion reactions.
Contraindications:
- Hypersensitivity to infliximab or any component of the formulation.
- Moderate to severe heart failure.
- Active infections, including tuberculosis.
Warnings and Precautions:
- Infections: Increased risk of serious infections; patients should be monitored for signs of infection.
- Malignancies: Increased risk of lymphomas and other malignancies in patients receiving TNF inhibitors.
- Hepatitis B Reactivation: Monitor patients for reactivation of hepatitis B virus.
Side Effects:
- Common: Infusion-related reactions (fever, chills, headache), nausea, and fatigue.
- Serious: Serious infections, liver failure, and allergic reactions.
Drug Interactions: Infliximab may interact with other immunosuppressive agents or biologics. Always inform healthcare providers of all medications being taken.
Storage: Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about the potential risks, including infections and allergic reactions.
- Advise patients to report any signs of infection, fever, or unusual symptoms promptly.
Conclusion: Remicade (Infliximab) 100 mg Injection is an effective treatment for several autoimmune conditions. Close monitoring for side effects and infections is essential for patient safety. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Genevac B Vaccine
Product Price: Rs 597 / PieceGet Best Price
Product Brochure
Product Details:
| Pack Size | 1 ml |
| Brand | Genevac-B |
| Composition | Hepatitis B Vaccine |
| Treatment | Prevention of Hepatitis B infection |
| Prescription/Non prescription | Non prescription |
| Form | Injection |
| Shelf life | 24 Month |
| Manufactured By | Serum Institute Of India Ltd |
| Country of Origin | Made in India |
Genevac B Vaccine
Indications: Genevac B is primarily indicated for:
- Hepatitis B Immunization: Prevention of hepatitis B virus infection in individuals at risk, including infants born to infected mothers, healthcare workers, and individuals with multiple sexual partners or chronic liver disease.
Mechanism of Action:
- Genevac B is a recombinant hepatitis B vaccine that works by stimulating the immune system to produce antibodies against the hepatitis B virus (HBV). It contains hepatitis B surface antigens that trigger an immune response without causing the disease.
Dosage and Administration:
- Dosage: The vaccine is typically administered in a series of three doses:
- First dose: at birth or as soon as possible.
- Second dose: 1 month after the first dose.
- Third dose: 6 months after the first dose.
- Administration: Given as an intramuscular injection, usually in the deltoid muscle for adults and older children, or in the anterolateral thigh for infants.
Contraindications:
- Hypersensitivity to any component of the vaccine.
- Moderate or severe acute illness (vaccination should be postponed until recovery).
Warnings and Precautions:
- Allergic Reactions: Monitor for signs of anaphylaxis or severe allergic reactions following vaccination.
- Immunocompromised Patients: The vaccine may be less effective in individuals with weakened immune systems.
Side Effects:
- Common: Pain at the injection site, fatigue, headache, and mild fever.
- Serious: Allergic reactions (anaphylaxis), though rare.
Drug Interactions: Genevac B may be administered simultaneously with other vaccines, but different injection sites should be used. Always inform healthcare providers of all medications and vaccines being administered.
Storage: Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about the importance of completing the vaccine series for full protection.
- Advise patients to report any unusual symptoms following vaccination.
Conclusion: Genevac B Vaccine is an effective preventive measure against hepatitis B virus infection. Adherence to the vaccination schedule and monitoring for side effects are crucial for optimal protection. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Exemptia 40 Mg/0.8ml Injection
Product Price: Rs 13,895 / VialGet Best Price
Product Brochure
Product Details:
| Strength / Dose | 40 mg / 0.8 ml |
| Manufacturer | Zydus |
| Packaging Type | Pre Filled Syringe |
| Brand | Exemptia |
| Composition | Adalimumab |
| Prescription/Non-Prescription | Prescription |
| Treatment | Ankylosing spondylitis |
Exemptia 40 mg/0.8 mL Injection (Adalimumab)
Indications:Exemptia is indicated for the treatment of:
- Moderate to severe rheumatoid arthritis in adults.
- Moderate to severe juvenile idiopathic arthritis in children aged 2 years and older.
- Psoriasis in adults and children aged 4 years and older.
- Ankylosing spondylitis.
- Crohn's disease and ulcerative colitis.
- Hidradenitis suppurativa.
- Uveitis.
Adalimumab is a monoclonal antibody that selectively binds to tumor necrosis factor-alpha (TNF-α), a cytokine involved in systemic inflammation. By inhibiting TNF-α, Exemptia reduces inflammatory responses and helps manage autoimmune conditions.
Dosage and Administration:- Dosage: The initial dose is usually 40 mg administered subcutaneously, followed by maintenance doses of 40 mg every other week, or as directed by a healthcare provider based on the specific condition and patient response.
- Administration: Administered subcutaneously. Patients may be trained to self-inject after proper instruction from healthcare providers.
- Hypersensitivity to adalimumab or any component of the formulation.
- Active infections, including tuberculosis.
- Severe heart failure.
- Infections: Increased risk of serious infections; monitor for signs of infection before and during treatment.
- Malignancies: Increased risk of certain cancers in patients receiving TNF inhibitors; assess risk factors.
- Neurological Effects: Caution in patients with a history of demyelinating disorders (e.g., multiple sclerosis).
Common side effects:
- Injection site reactions (pain, redness, swelling)
- Headache
- Nausea
- Rash
Serious side effects:
- Serious infections (e.g., tuberculosis, bacterial, viral)
- Allergic reactions (anaphylaxis)
- Liver dysfunction
- Heart failure exacerbation
Adalimumab may interact with other immunosuppressive agents or biologics. Inform healthcare providers of all medications being taken.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. Protect from light. Allow the injection to reach room temperature before use.
Patient Counseling Information:- Advise patients on how to recognize signs of infection and when to seek medical attention.
- Discuss the importance of regular follow-up appointments to monitor response and any potential side effects.
- Instruct on proper self-injection techniques, if applicable.
Exemptia 40 mg/0.8 mL Injection (Adalimumab) is an effective treatment option for various autoimmune conditions. Regular monitoring and open communication with healthcare providers are essential for safe and effective use. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Romiplostim Injection(Romy Injection)
Product Price: Rs 3,000 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 250 mcg |
| Brand | Romy |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packaging Size | 0.5 ml in 1 vial |
| Country of Origin | Made in India |
| Treatment | On-going safe thrombocytopenia |
Romiplostim Injection (Romy Injection)
Indications:Romy Injection is indicated for:
- The treatment of chronic immune thrombocytopenic purpura (ITP) in adults who have had an insufficient response to other treatments.
- Increasing platelet counts in patients with ITP to reduce the risk of bleeding.
Romiplostim is a thrombopoietin receptor agonist. It binds to and activates the thrombopoietin receptor (c-Mpl), stimulating megakaryocyte and platelet production in the bone marrow. This action increases platelet counts and helps manage the symptoms associated with thrombocytopenia.
Dosage and Administration:- Dosage: The initial recommended dose is typically 1 mcg/kg administered subcutaneously once weekly. The dose may be adjusted based on the patient's response and platelet counts.
- Administration: Inject subcutaneously into the thigh, abdomen, or upper arm. Rotate injection sites to reduce the risk of local irritation.
- Hypersensitivity to romiplostim or any component of the formulation.
- The presence of a bone marrow disorder or malignancy that affects platelet production.
- Thrombosis: Monitor for signs of thrombosis, as there is an increased risk with elevated platelet counts.
- Bone Marrow: Regular monitoring of blood counts is essential, as romiplostim can lead to changes in bone marrow cellularity.
- Allergic Reactions: Be alert for signs of serious allergic reactions, including anaphylaxis.
Common side effects:
- Fatigue
- Headache
- Dizziness
- Nausea
- Injection site reactions (pain, redness, swelling)
Serious side effects:
- Thromboembolic events (e.g., stroke, myocardial infarction)
- Severe allergic reactions
- Bone marrow fibrosis (rare)
Romiplostim may interact with other medications that affect platelet function or coagulation. Always inform healthcare providers about all medications being taken, including over-the-counter drugs and supplements.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Do not freeze. Protect from light and keep out of reach of children.
Patient Counseling Information:- Advise patients on the importance of regular follow-up visits for blood count monitoring.
- Instruct patients on proper injection technique and site rotation.
- Discuss potential side effects and when to seek medical attention, particularly for signs of thrombosis or allergic reactions.
Romiplostim Injection (Romy Injection) is an effective treatment option for adults with chronic ITP, helping to increase platelet counts and reduce bleeding risks. Adherence to the treatment regimen and communication with healthcare providers are essential for optimal outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Protamine Sulfate Injection (Neutrahep 10mg Injection)
Product Price: Rs 17 / PieceGet Best Price
Product Brochure
Product Details:
| Packaging Type | 5X5 ml Vials |
| Composition | Protamine sulfate 10mg |
| Brand | Neutrahep |
| Manufacturer | Gland Pharma Limited |
| Dose | 10 mg |
| Usage/Application | Heparin glut |
Overview: Protamine sulfate is a medication primarily used to reverse the effects of heparin, an anticoagulant (blood thinner). It is especially important in situations where rapid reversal of heparin is needed, such as during or after surgery.
Indications:
- Heparin Overdose: Used to counteract the effects of heparin in cases of overdose or excessive anticoagulation.
- Surgical Procedures: Administered after procedures involving heparin to restore normal blood clotting.
Mechanism of Action: Protamine sulfate works by binding to heparin to form a stable complex that neutralizes its anticoagulant effects. This reversal allows for the restoration of normal coagulation.
Dosage and Administration:
- Dosage: The dosage depends on the amount of heparin administered and the clinical situation. A typical starting dose may be 1 mg of protamine for every 100 units of heparin, but this should be calculated based on specific circumstances.
- Administration: Given intravenously, typically slowly to avoid adverse reactions.
Contraindications:
- Hypersensitivity to protamine sulfate or any of its components.
- Caution in patients with fish allergies (as protamine is derived from fish sperm) and those with a history of allergic reactions to protamine.
Warnings and Precautions:
- Monitor for allergic reactions, including anaphylaxis.
- Use with caution in patients with a history of bleeding disorders or low platelet counts.
Side Effects:
- Common: Flushing, hypotension, bradycardia, and nausea.
- Serious: Severe allergic reactions and cardiovascular effects.
Drug Interactions:
- May interact with other anticoagulants or medications affecting blood clotting. Always inform healthcare providers of all medications being taken.
Storage:
- Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture.
Patient Counseling:
- Inform patients about the purpose of the injection and possible side effects.
- Advise them to report any unusual symptoms, particularly signs of allergic reactions.
Conclusion: Protamine Sulfate Injection (Neutrahep 10 mg) is an essential agent for reversing heparin’s anticoagulant effects in critical situations. Proper administration and monitoring are vital for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Pantoprazole 40 Injection (Pantodac Iv)
Product Price: Rs 39 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 40 mg |
| Form | Injection |
| Brand Name | Pantodac IV |
| Manufacturer | Zydus Corza |
| Country of Origin | Made in India |
| Treatment | Heartburn |
Pantoprazole 40 mg Injection (Pantodac IV)
Overview: Pantoprazole is a proton pump inhibitor (PPI) used primarily for reducing gastric acid secretion.
Indications:
- Gastroesophageal Reflux Disease (GERD): Short-term treatment of erosive esophagitis caused by GERD.
- Zollinger-Ellison Syndrome: Management of conditions with excessive stomach acid production.
- Prevention of Stress Ulcers: For hospitalized patients at risk of stress-related mucosal disease.
Mechanism of Action: Pantoprazole works by inhibiting the hydrogen/potassium ATPase enzyme in gastric parietal cells, leading to decreased acid secretion.
Dosage and Administration:
- Dosage: 40 mg intravenously once daily.
- Administration: Given as an intravenous infusion; do not mix with other medications.
Contraindications:
- Known hypersensitivity to pantoprazole or any formulation component.
- Use with caution in patients with severe liver impairment.
Warnings and Precautions:
- Monitor for signs of gastrointestinal infections, especially Clostridium difficile.
- Prolonged use may lead to vitamin B12 or magnesium deficiencies.
- Potential association with acute interstitial nephritis.
Side Effects:
- Common: Nausea, vomiting, diarrhea, headache, injection site reactions.
- Serious: Risk of Clostridium difficile infection, acute kidney injury, and allergic reactions.
Drug Interactions: May interact with medications that need an acidic environment for absorption. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
Patient Counseling:
- Discuss potential side effects, particularly gastrointestinal symptoms.
- Advise patients to report any unusual symptoms, especially severe diarrhea or allergic reactions.
Conclusion: Pantoprazole Injection (Pantodac IV) 40 mg is effective for treating acid-related gastrointestinal conditions, with careful administration and monitoring essential for safety. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Amikacin Injection (Omnikacin 500mg Injection)
Product Price: Rs 89 / PieceGet Best Price
Product Brochure
Product Details:
| Dose | 500 mg/ 2ml |
| Packaging Type | Vial |
| Form | Injection |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
| Brand | Omnikacin |
| Manufacturer | Cipla |
| Treatment | Bacterial infections |
Amikacin Injection (Omnikacin 500 mg Injection)
Indications: Omnikacin (Amikacin) is primarily indicated for:
- Bacterial Infections: Treatment of severe infections caused by susceptible strains of gram-negative bacteria, including infections of the respiratory tract, urinary tract, and soft tissues.
- Tuberculosis: Used as part of a multidrug regimen for the treatment of multidrug-resistant tuberculosis.
Mechanism of Action: Amikacin is an aminoglycoside antibiotic that works by:
- Inhibiting bacterial protein synthesis by binding to the 30S ribosomal subunit, which disrupts the function of ribosomes and prevents bacterial growth.
Dosage and Administration:
- Dosage: The typical dose for adults is 15 mg/kg/day, divided into one to three doses, depending on the severity of the infection and renal function. Dosage adjustments may be necessary for renal impairment.
- Administration: Administered via intravenous infusion or intramuscular injection. The route and method of administration should be determined by healthcare professionals.
Contraindications:
- Hypersensitivity to amikacin or any aminoglycoside antibiotic.
- Preexisting hearing loss or significant renal impairment.
Warnings and Precautions:
- Nephrotoxicity: Monitor kidney function closely, especially in patients with preexisting renal conditions or those receiving other nephrotoxic medications.
- Ototoxicity: Hearing function should be monitored, particularly in prolonged treatment or in patients with risk factors for hearing loss.
- Neuromuscular Blockade: Use with caution in patients with neuromuscular disorders, as amikacin may enhance neuromuscular blockade.
Side Effects:
- Common: Nausea, vomiting, rash, and injection site reactions (pain, swelling).
- Serious: Nephrotoxicity, ototoxicity, and allergic reactions (including anaphylaxis).
Drug Interactions: Amikacin may interact with other medications, especially those that are nephrotoxic or ototoxic. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about the importance of adhering to the prescribed dosage and the need for monitoring.
- Advise patients to report any signs of hearing loss, kidney issues, or allergic reactions during treatment.
Conclusion: Omnikacin (Amikacin) 500 mg Injection is an effective treatment for severe bacterial infections. Close monitoring for potential side effects and professional administration are essential for ensuring safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Folisurge 1200 IU Injection
Product Price: Rs 13,500 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 1200IU |
| Packaging Type | Vial |
| Packaging Size | 1 ml in 1 vial |
| Composition | Recombinant follicle stimulating hormone 1200IU |
| Brand | Intas |
| Injectable Form | Liquid |
Folisurge 1200 IU Injection
Indications:Folisurge is indicated for:
- Ovulation induction in women with anovulation or oligo-ovulation due to polycystic ovary syndrome (PCOS).
- Stimulation of follicular development in women undergoing assisted reproductive techniques, such as in vitro fertilization (IVF).
- Treatment of infertility in women with hormone imbalances.
Folisurge contains follicle-stimulating hormone (FSH), which is essential for the development and maturation of ovarian follicles. By stimulating the ovaries, it promotes follicular growth and enhances the chances of ovulation.
Dosage and Administration:- Dosage: The dosage may vary based on the specific indication and patient response. A common starting dose is 1200 IU, administered subcutaneously or intramuscularly. Dosing schedules can be adjusted based on monitoring and individual patient needs.
- Administration: Administered by a healthcare professional. Instruct patients on proper injection technique if self-administered.
- Hypersensitivity to FSH or any component of the formulation.
- Ovarian cysts or enlargement not due to polycystic ovary syndrome.
- Uncontrolled adrenal or thyroid disorders.
- Pregnancy.
- Ovarian Hyperstimulation Syndrome (OHSS): Monitor for signs of OHSS, which can occur with ovarian stimulation. This condition may lead to severe abdominal pain, nausea, vomiting, and fluid accumulation.
- Multiple Pregnancies: Increased risk of multiple pregnancies with ovarian stimulation.
- Caution in Certain Conditions: Use cautiously in women with a history of hormone-sensitive cancers or those with liver or kidney disease.
Common side effects:
- Injection site reactions (pain, redness, swelling)
- Abdominal discomfort or pain
- Headaches
- Nausea
Serious side effects:
- Ovarian hyperstimulation syndrome (OHSS)
- Severe allergic reactions (anaphylaxis)
- Multiple pregnancies
Inform healthcare providers about all medications being taken, as certain drugs may affect ovarian function or interact with FSH.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Protect from light. Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Instruct patients on proper injection technique and how to recognize signs of OHSS.
- Discuss the potential for multiple pregnancies and the importance of monitoring during treatment.
- Encourage regular follow-up appointments to assess treatment response and adjust dosing as needed.
Folisurge 1200 IU Injection is an effective treatment for inducing ovulation and managing infertility. Close monitoring and communication with healthcare providers are essential for optimizing treatment outcomes and managing potential side effects. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Cresemba 200mg Injection
Product Price: Rs 4,628 / VialGet Best Price
Product Brochure
Product Details:
| Composition | Isavuconazole |
| Treatment | Invasive Aspergillosis |
| Prescription/Non prescription | Non prescription |
| Brand Name | Isavuconazole |
| Manufacture | Cresemba |
Cresemba (Isavuconazole) 200 mg Injection
Overview: Cresemba is an antifungal medication used to treat serious fungal infections, particularly those caused by Aspergillus and Candida species.
Indications:
- Invasive Aspergillosis: Treatment in patients who are intolerant to or have failed other antifungal therapies.
- Invasive Mucormycosis: For the treatment of this serious fungal infection in patients who are appropriate candidates for treatment.
Mechanism of Action: Isavuconazole inhibits the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to cell death. It has a broad spectrum of activity against various fungi.
Dosage and Administration:
- Dosage: The typical loading dose is 372 mg (equivalent to 200 mg of isavuconazole) given three times on the first day, followed by a maintenance dose of 200 mg once daily.
- Administration: Administered via intravenous infusion over approximately 1 hour. Proper dilution and administration techniques should be followed.
Contraindications:
- Hypersensitivity to isavuconazole or any component of the formulation.
- Concurrent use with strong CYP450 3A4 inhibitors or inducers.
Warnings and Precautions:
- Monitor for signs of liver toxicity and skin reactions during treatment.
- Caution in patients with a history of heart conditions, as isavuconazole can cause changes in cardiac conduction.
Side Effects:
- Common: Nausea, vomiting, diarrhea, headache, and infusion site reactions.
- Serious: Risk of liver enzyme elevations, hypersensitivity reactions, and cardiac arrhythmias.
Drug Interactions: Isavuconazole is metabolized by the CYP450 system, so interactions with other medications that affect these enzymes should be carefully monitored.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients about the purpose of the injection and potential side effects.
- Advise them to report any unusual symptoms, especially signs of liver dysfunction or allergic reactions.
Conclusion: Cresemba (Isavuconazole) 200 mg Injection is a vital antifungal treatment for invasive fungal infections. Proper administration and monitoring are essential for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Themiset 75mg Injection ( 1.5 Ml )
Product Price: Rs 60 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 75mg |
| Packaging Type | Vial |
| Brand Name | Themiset |
| Manufacturer | Themis Medicare Ltd |
| Country of Origin | Made in India |
| Treatment | Nausea |
| Composition | Palonosetron 75 mg |
| Prescription/Non prescription | Prescription |
| Form | Injection |
| Packaging Size | 1.5 ml |
| Dose | 75 mg |
Themiset 75 mg Injection (Thiotepa)
Indications: Themiset (Thiotepa) is primarily indicated for:
- Chemotherapy: Used in the treatment of various types of cancer, including breast cancer, ovarian cancer, and bladder cancer.
- Conditioning Regimen: As part of a regimen for patients undergoing hematopoietic stem cell transplantation.
Mechanism of Action: Thiotepa is an alkylating agent that works by:
- Interfering with DNA replication and transcription, leading to cell death.
- Its cytotoxic effects target rapidly dividing cells, which is characteristic of cancerous tissues.
Dosage and Administration:
- Dosage: The dosage varies depending on the type of cancer being treated and the treatment protocol. It is typically administered as a single dose or as part of a multi-day regimen. Dosages may range from 75 mg to higher doses based on clinical judgment.
- Administration: Administered via intravenous injection or infusion. Dosing should be done by healthcare professionals experienced in chemotherapy administration.
Contraindications:
- Hypersensitivity to thiotepa or any component of the formulation.
- Pregnancy and breastfeeding, unless the potential benefits outweigh the risks.
Warnings and Precautions:
- Bone Marrow Suppression: Monitor blood counts regularly, as thiotepa can cause myelosuppression, leading to increased risk of infection and bleeding.
- Potential for Secondary Malignancies: Long-term use may increase the risk of secondary cancers.
- Renal Impairment: Use with caution in patients with renal impairment, as dosage adjustments may be necessary.
Side Effects:
- Common: Nausea, vomiting, fatigue, mucositis, and hair loss.
- Serious: Severe bone marrow suppression, allergic reactions, and signs of infection.
Drug Interactions: Thiotepa may interact with other chemotherapeutic agents and medications that can affect blood counts. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
Patient Counseling Information:
- Discuss potential side effects and the importance of regular monitoring.
- Advise patients to report any signs of infection, unusual bleeding, or severe gastrointestinal symptoms.
Conclusion: Themiset (Thiotepa) 75 mg Injection is an important chemotherapeutic agent used in the management of various cancers. Close monitoring and professional administration are essential for maximizing treatment efficacy and minimizing side effects. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
B Complex Extract With Vitamin B12 Injection(Optineuron Injection )
Product Price: Rs 140 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 2500mcg |
| Brand Name | Optineuron |
| Manufacturer Name | Lupin Ltd |
| Prescription/Non-Prescription | Non-Prescription |
| Country of Origin | Made in India |
| Treatment | Nutritional deficiencies |
| Packaging Size | 3 ml in 1 ampoule |
B Complex Extract with Vitamin B12 Injection (Optineuron Injection)
Indications:Optineuron Injection is indicated for:
- Vitamin B deficiency, including B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B9 (folate), and B12 (cobalamin).
- Conditions related to neurological health, including neuropathies and neurodegenerative disorders.
- Supportive therapy in various metabolic and hematologic disorders.
The B vitamins in this injection play vital roles in energy metabolism, red blood cell formation, and neurological function. They contribute to the synthesis of neurotransmitters and support the overall health of the nervous system.
Dosage and Administration:- Dosage: The recommended dosage is typically 1 to 2 mL administered intramuscularly or intravenously, depending on the clinical condition and patient response.
- Administration: Administered by healthcare professionals, ensuring proper technique to minimize discomfort and risk of infection.
- Hypersensitivity to any components of the formulation.
- Certain contraindications may apply depending on specific patient conditions; consult a healthcare provider.
- Allergic Reactions: Monitor for any signs of allergic reactions, including rash or anaphylaxis.
- Renal Impairment: Use with caution in patients with renal issues, particularly those receiving high doses of Vitamin B12.
Common side effects:
- Injection site reactions (pain, swelling, redness)
- Mild gastrointestinal disturbances (nausea, diarrhea)
- Allergic reactions (rare)
Serious side effects:
- Severe allergic reactions (anaphylaxis)
- Symptoms of vitamin toxicity with excessive dosing (rare)
B vitamins generally have low interaction potential, but high doses may affect the absorption of certain medications. Always inform healthcare providers of all medications being taken, including over-the-counter drugs and supplements.
Storage:Store in a refrigerator (2°C to 8°C / 36°F to 46°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:- Advise patients to report any unusual symptoms or allergic reactions after the injection.
- Discuss the importance of adhering to any prescribed follow-up treatments or dietary recommendations.
- Encourage maintaining a balanced diet rich in B vitamins.
B Complex Extract with Vitamin B12 Injection (Optineuron) is a valuable therapeutic option for managing vitamin B deficiencies and supporting neurological health. Regular monitoring and communication with healthcare providers are essential for optimizing treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Fluconazole Injection (FORCAN 2mg/Ml Injection )
Product Price: Rs 89 / PackGet Best Price
Product Brochure
Product Details:
| Strength | 200mg |
| Composition | Fluconazole 200 mg |
| Manufacturer | Cipla ltd |
| Country of Origin | Made in India |
| Dose | 2 mg/ml |
| Brand Name | Forcan |
| Treatment | Fungal contaminations |
Fluconazole Injection (Forcan 2 mg/mL)
Indications: Forcan (Fluconazole) is primarily indicated for:
- Fungal Infections: Treatment of various fungal infections, including:
- Candidemia (bloodstream infections caused by Candida).
- Candidiasis (including esophageal candidiasis and oropharyngeal candidiasis).
- Cryptococcal meningitis in patients with HIV/AIDS.
- Prophylaxis for fungal infections in immunocompromised patients.
Mechanism of Action: Fluconazole is an antifungal medication that works by:
- Inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to cell membrane disruption and death of the fungus.
Dosage and Administration:
- Dosage:
- The typical initial dose is 400 mg, followed by a maintenance dose of 200 to 400 mg once daily, depending on the type and severity of the infection.
- Administration: Fluconazole is administered intravenously. The infusion should be given over a period of 1 to 2 hours.
Contraindications:
- Hypersensitivity to fluconazole or any component of the formulation.
- Coadministration with certain medications that may interact adversely (e.g., some anticoagulants).
Warnings and Precautions:
- Liver Function: Monitor liver function tests, as fluconazole can cause hepatic toxicity.
- Cardiac Arrhythmias: Use with caution in patients with a history of cardiac arrhythmias, as fluconazole may prolong the QT interval.
- Pregnancy and Lactation: Use during pregnancy only if the benefits outweigh the risks. Caution is advised when breastfeeding.
Side Effects:
- Common: Nausea, headache, dizziness, and abdominal pain.
- Serious: Hepatic toxicity, severe allergic reactions, and potential for QT interval prolongation.
Drug Interactions: Fluconazole may interact with other medications, particularly those metabolized by the liver. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Counseling Information:
- Educate patients about potential side effects and the importance of adhering to the prescribed treatment regimen.
- Advise patients to report any unusual symptoms, especially signs of liver dysfunction (e.g., jaundice, dark urine) or allergic reactions.
Conclusion: Forcan (Fluconazole) Injection 2 mg/mL is an effective treatment option for various fungal infections. Proper administration and monitoring for side effects are essential for safe and effective therapy. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Ethamsylate Injection (Ethamo 125mg Injection )
Product Price: Rs 250 / PieceGet Best Price
Minimum Order Quantity: 10 Piece
Product Brochure
Product Details:
| Strength | 125 mg |
| Manufacturer | Biochem Pharmaceutical Industries |
| Composition | Ethamsylate 125mg |
| Brand | Ethamo |
| Dose/Strength | 125 mg |
| Pack Size | 2 ml in 1 vial |
| Treatment | Bleeding |
Yes! I am InterestedRequest A Callback
View More